Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31-April 1, 2016, Tours, France

被引：25

作者：

Desoubeaux, Guillaume ^{[1
,2
,3
]}

Reichert, Janice M. ^{[4
,5
]}

Sleeman, Matthew ^{[6
]}

Reckamp, Karen L. ^{[7
]}

Ryffel, Bernhard ^{[8
,9
]}

Adamczewski, Joerg P. ^{[10
]}

Sweeney, Theresa D. ^{[11
]}

Vanbever, Rita ^{[12
]}

Diot, Patrice ^{[1
,2
,3
]}

Owen, Caroline A. ^{[13
,14
]}

Page, Clive ^{[15
]}

Lerondel, Stephanie ^{[16
]}

Le Pape, Alain ^{[1
,2
,16
]}

Heuze-Vourc'h, Nathalie ^{[1
,2
]}

机构：

[1] Univ Tours, Tours, France

[2] INSERM, Ctr Etud Pathol Resp, Tours, France

[3] Ctr Hosp Univ Tours, Tours, France

[4] Antibody Soc, Framingham, MA USA

[5] Reichert Biotechnol Consulting LLC, Framingham, MA USA

[6] MedImmune, Cambridge, England

[7] City Hope Natl Med Ctr, Ctr Comprehens Canc, Duarte, CA USA

[8] Univ Orleans, Orleans, France

[9] Univ Cape Town, Inst Infect Dis & Mol Med IDM, Cape Town, South Africa

[10] Sanofi R&D, Chilly Mazarin, France

[11] Nektar Therapeut, San Francisco, CA USA

[12] Catholic Univ Louvain, Louvain Drug Res Inst, Brussels, Belgium

[13] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA

[14] Lovelace Resp Res Inst, Albuquerque, NM USA

[15] Kings Coll London, Sackler Inst Pulm Pharmacol, London, England

[16] PHENOMIN TAAM CNRS, CIPA, Orleans, France

来源：

MABS | 2016年 / 8卷 / 06期

关键词：

Antibody therapeutics; animal models; innovation; infectious diseases; inhalation; respiratory diseases; CELL LUNG-CANCER; SYNCYTIAL VIRUS-INFECTION; 1ST-LINE THERAPY; CIGARETTE-SMOKE; OPEN-LABEL; BRONCHIAL HYPERRESPONSIVENESS; CONTROLLED PHASE-3; PLUS GEMCITABINE; AEROSOL THERAPY; INFLAMMATION;

D O I：

10.1080/19420862.2016.1196521

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Monoclonal antibody (mAb) therapeutics have tremendous potential to benefit patients with lung diseases, for which there remains substantial unmet medical need. To capture the current state of mAb research and development in the area of respiratory diseases, the Research Center of Respiratory Diseases (CEPR-INSERM U1100), the Laboratory of Excellence MAbImprove, the GDR 3260 Antibodies and therapeutic targeting, and the Grant Research program ARD2020 Biotherapeutics invited speakers from industry, academic and government organizations to present their recent research results at the Therapeutic Monoclonal Antibodies for Respiratory Diseases: Current challenges and perspectives congress held March 31 - April 1, 2016 in Tours, France.

引用

页码：999 / 1009

页数：11

共 60 条

[1] Inflammasome-IL-1-Th17 response in allergic lung inflammation
Besnard, Anne-Gaelle
Togbe, Dieudonnee
Couillin, Isabelle
Tan, Zoming
Zheng, Song Guo
Erard, Francois
Le Bert, Marc
Quesniaux, Valerie
Ryffel, Bernhard
[J]. JOURNAL OF MOLECULAR CELL BIOLOGY, 2012, 4 (01) : 3 - 10
[2] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
Borghaei, H.
Paz-Ares, L.
Horn, L.
Spigel, D. R.
Steins, M.
Ready, N. E.
Chow, L. Q.
Vokes, E. E.
Felip, E.
Holgado, E.
Barlesi, F.
Kohlhaeufl, M.
Arrieta, O.
Burgio, M. A.
Fayette, J.
Lena, H.
Poddubskaya, E.
Gerber, D. E.
Gettinger, S. N.
Rudin, C. M.
Rizvi, N.
Crino, L.
Blumenschein, G. R.
Antonia, S. J.
Dorange, C.
Harbison, C. T.
Finckenstein, F. Graf
Brahmer, J. R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) : 1627 - 1639
[3] The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one]
Boswell-Smith, Victoria
Spina, Domenico
Oxford, Alec W.
Comer, Mike B.
Seeds, Esther A.
Page, Clive P.
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (02) : 840 - 848
[4] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Brahmer, Julie
Reckamp, Karen L.
Baas, Paul
Crino, Lucio
Eberhardt, Wilfried E. E.
Poddubskaya, Elena
Antonia, Scott
Pluzanski, Adam
Vokes, Everett E.
Holgado, Esther
Waterhouse, David
Ready, Neal
Gainor, Justin
Aren Frontera, Osvaldo
Havel, Libor
Steins, Martin
Garassino, Marina C.
Aerts, Joachim G.
Domine, Manuel
Paz-Ares, Luis
Reck, Martin
Baudelet, Christine
Harbison, Christopher T.
Lestini, Brian
Spigel, David R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) : 123 - 135
[5] The receptor NLRP3 is a transcriptional regulator of TH2 differentiation (vol 16, pg 859, 2015)
Bruchard, Melanie
Rebe, Cedric
Derangere, Valentin
Togbe, Dieudonnee
Ryffel, Bernhard
Boidot, Romain
Humblin, Etienne
Hamman, Arlette
Chalmin, Fanny
Berger, Helene
Chevriaux, Angelique
Limagne, Emeric
Apetoh, Lionel
Vegran, Frederique
Ghiringhelli, Francois
[J]. NATURE IMMUNOLOGY, 2015, 16 (12) : 1292 - 1292
[6] Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Cohen, E. Suzanne u
Scott, Ian C.
Majithiya, Jayesh B.
Rapley, Laura
Kemp, Benjamin P.
England, Elizabeth
Rees, D. Gareth
Overed-Sayer, Catherine L.
Woods, Joanne
Bond, Nicholas J.
Veyssier, Christel Seguy
Embrey, Kevin J.
Sims, Dorothy A.
Snaith, Michael R.
Vousden, Katherine A.
Strain, Martin D.
Chan, Denice T. Y.
Carmen, Sara
Huntington, Catherine E.
Flavell, Liz
Xu, Jianqing
Popovic, Bojana
Brightling, Christopher E.
Vaughan, Tristan J.
Butler, Robin
Lowe, David C.
Higazi, Daniel R.
Corkill, Dominic J.
May, Richard D.
Sleeman, Matthew A.
Mustelin, Tomas
[J]. NATURE COMMUNICATIONS, 2015, 6
[7] Microdialysis in peripheral tissues
de la Peña, A
Liu, P
Derendorf, H
[J]. ADVANCED DRUG DELIVERY REVIEWS, 2000, 45 (2-3) : 189 - 216
[8] Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab
De Santis, Rita
Rosi, Antonio
Anastasi, Anna Maria
Chiapparino, Caterina
Albertoni, Claudio
Leoni, Barbara
Pelliccia, Angela
Santapaola, Daniela
Carollo, Valeria
Marra, Emanuele
Aurisicchio, Luigi
Arseni, Brunilde
Pacello, Maria Lucrezia
Palmieri, Gabriella
Battella, Simone
Petronzelli, Fiorella
Milazzo, Ferdinando Maria
[J]. ONCOTARGET, 2014, 5 (19) : 9239 - 9255
[9] Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Detalle, Laurent
Stohr, Thomas
Palomo, Concepcion
Piedra, Pedro A.
Gilbert, Brian E.
Mas, Vicente
Millar, Andrena
Power, Ultan F.
Stortelers, Catelijne
Allosery, Koen
Melero, Jose A.
Depla, Erik
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 6 - 13
[10] Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Dijkers, Eli C. F.
Kosterink, Jos G. W.
Rademaker, Anna P.
Perk, Lars R.
van Dongen, Guus A. M. S.
Bart, Joost
de Jong, Johan R.
de Vries, Elisabeth G. E.
Lub-de Hooge, Marjolijn N.
[J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) : 974 - 981

← 1 2 3 4 5 6 →